Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC

UR Medicine

menu
UR Medicine / Neurosurgery / Services / Pituitary Program / Program Overview
 

Program Overview

The UR Medicine Pituitary Program is formed from a group of physicians, nurse practitioners, scientists, administrators, secretaries, and staff drawn from departments across the University of Rochester Medical Center and campus.

We seek to provide highly coordinated care in neurosurgery, endocrinology, radiation oncology and neuro-ophthalmology for all patients afflicted with tumors in the pituitary gland or the hypothalamic-pituitary region. We utilize the newest technologies and treatments available anywhere in the world, and deliver patient care with compassion and understanding of the many complexities involved in treating patients with these disorders.

Our goal is to help patients and their families navigate the complex issues surrounding disorders of the pituitary gland and hypothalamus.

Our Mission & Philosophy

Mission: The UR Medicine Pituitary Program will be a world leader in the discovery, development, and delivery of compassionate, innovative, and effective care for patients afflicted with disorders of the pituitary gland and hypothalamus. Philosophy: We are a resource for our patients to help them fight and manage their disease. We work as a team to recommend the best therapies and to adapt promising new technologies and approaches as soon as they become available. We are encouraged by advances in basic science and translational research at the University of Rochester and within the medical community at large, and we strive to partner with our patients to convert these findings into better outcomes for everyone.

Research Initiatives

The UR Medicine Pituitary Program, in conjunction with the Program for Brain and Spinal Tumors, is committed to making available current treatment options as well as new clinical trial opportunities for patients with pituitary and hypothalamic disorders and tumors. We strongly believe that future progress in treating these diseases will be made through ongoing basic and clinical research..